These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3561892)

  • 1. Diabetic rat serum has an increased capacity to inhibit brain microtubule formation in vitro.
    McLean WG; Beahon SJ; Casson IF
    Neurochem Pathol; 1986 Jun; 4(3):165-76. PubMed ID: 3561892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of variation in turnover of glycated albumin on indices of diabetic control.
    Johnson RN; Easdale RW; Tatnell M; Baker JR
    Clin Chim Acta; 1991 May; 198(3):229-38. PubMed ID: 1889123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of non-enzymatic glycation of serum proteins on their permeation into peripheral nerve in normal and streptozotocin-diabetic rats.
    Patel NJ; Misra VP; Dandona P; Thomas PK
    Diabetologia; 1991 Feb; 34(2):78-80. PubMed ID: 2065852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal evaluation of the renal clearance of glycated albumin in the diabetic rat.
    Layton GJ; Allen TJ; Jerums G
    Diabetes Res Clin Pract; 1990 Mar; 8(3):221-6. PubMed ID: 2340793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated albumin: a marker of glycaemic status in rats with experimental diabetes.
    Neuman RG; Hud E; Cohen MP
    Lab Anim; 1994 Jan; 28(1):63-9. PubMed ID: 8158971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated albumin and serum protein in diabetic dogs.
    Mahaffey EA; Buonanno AM; Cornelius LM
    Am J Vet Res; 1984 Oct; 45(10):2126-8. PubMed ID: 6238559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus.
    Cullum NA; Mahon J; Stringer K; McLean WG
    Diabetologia; 1991 Jun; 34(6):387-9. PubMed ID: 1715829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive immunization suppresses advanced glycation and mitigates diabetic nephropathy.
    Shcheglova T; Makker S; Tramontano A
    J Am Soc Nephrol; 2009 May; 20(5):1012-9. PubMed ID: 19389854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against impaired brain microtubule protein polymerization at high glucose concentrations or during diabetes mellitus.
    Eaker EY; Angelastro JM; Purich DL; Sninsky CA
    J Neurochem; 1991 Jun; 56(6):2087-93. PubMed ID: 2027016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction.
    Ido Y; Kilo C; Williamson JR
    Nephrol Dial Transplant; 1996; 11 Suppl 5():72-5. PubMed ID: 9044312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of diabetes-associated abnormalities in the vitreous fluid by an inhibitor of albumin glycation.
    Cohen MP; Hud E; Wu VY; Shearman CW
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5089-93. PubMed ID: 18599566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver and kidney tissue membranes as tissue markers for nonenzymatic glycosylation.
    Cefalu WT; Wang ZQ; Bell-Farrow A; Ralapati S
    Diabetes; 1991 Jul; 40(7):902-7. PubMed ID: 2060726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of glycated albumin to blood glucose change in the circulation in streptozotocin-diabetic rats--comparison of theoretical values with experimental data.
    Shi K; Tahara Y; Noma Y; Yasukawa K; Shima K
    Diabetes Res Clin Pract; 1992 Sep; 17(3):153-60. PubMed ID: 1425154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation accelerates albumin degradation in normal and diabetic dogs.
    Morris MA; Preddy L
    Biochem Med Metab Biol; 1986 Jun; 35(3):267-70. PubMed ID: 3521682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy.
    Eaton JW; Qian M
    Mol Cell Biochem; 2002; 234-235(1-2):135-42. PubMed ID: 12162426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential excretion of glycated albumin in C57BL-Ks-J mice: effects of diabetes.
    Kowluru A; Kowluru RA
    Experientia; 1992 May; 48(5):486-8. PubMed ID: 1601114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycation of albumin, not glomerular basement membrane, alters permeability in an in vitro model.
    Daniels BS; Hauser EB
    Diabetes; 1992 Nov; 41(11):1415-21. PubMed ID: 1397717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The improvement effect of L-Lys as a chemical chaperone on STZ-induced diabetic rats, protein structure and function.
    Jafarnejad A; Bathaie SZ; Nakhjavani M; Hassan MZ; Banasadegh S
    Diabetes Metab Res Rev; 2008; 24(1):64-73. PubMed ID: 17879961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. d-Ribose contributes to the glycation of serum protein.
    Chen Y; Yu L; Wang Y; Wei Y; Xu Y; He T; He R
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2285-2292. PubMed ID: 31085227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling the molecular mechanisms underpinning biorecognition of early-glycated human serum albumin and receptor for advanced glycation end products.
    Tramarin A; Naldi M; Degani G; Lupu L; Wiegand P; Mazzolari A; Altomare A; Aldini G; Popolo L; Vistoli G; Przybylski M; Bartolini M
    Anal Bioanal Chem; 2020 Jul; 412(18):4245-4259. PubMed ID: 32367292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.